» Authors » Akira Kurosaki

Akira Kurosaki

Explore the profile of Akira Kurosaki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 133
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hasegawa K, Nishio S, Yamamoto K, Fujiwara H, Itagaki H, Nagai T, et al.
Eur J Cancer . 2025 Feb; 219:115304. PMID: 40010135
Aim: Concurrent chemoradiotherapy (CCRT) is the standard treatment for locally advanced cervical cancer (LACC), but recurrence rates remain high. This multicenter phase-3 randomized trial (GOTIC-002) evaluated the efficacy of low-dose...
2.
Nishijima A, Oda K, Hasegawa K, Koso T, Asada K, Ikeda Y, et al.
Sci Rep . 2024 Aug; 14(1):18797. PMID: 39138354
The cellular origin of clear cell ovarian carcinoma (CCOC), a major histological subtype of ovarian carcinoma remains elusive. Here, we explored the candidate cellular origin and identify molecular subtypes using...
3.
Kurosaki A
Gan To Kagaku Ryoho . 2024 Mar; 51(2):138-141. PMID: 38449398
No abstract available.
4.
5.
Sato M, Sato S, Shintani D, Hanaoka M, Ogasawara A, Miwa M, et al.
BMC Cancer . 2022 Jan; 22(1):59. PMID: 35027024
Background: Administration of poly (ADP-ribose) polymerase (PARP) inhibitors after achieving a response to platinum-containing drugs significantly prolonged relapse-free survival compared to placebo administration. PARP inhibitors have been used in clinical...
6.
Sato M, Shintani D, Hanaoka M, Sato S, Miwa M, Ogasawara A, et al.
Mol Clin Oncol . 2021 Aug; 15(4):207. PMID: 34462663
Digital colposcopy built around a smartphone is becoming common, and this has advantages for telemedicine and data sharing by taking advantage of smartphone characteristics. However, digital colposcopy itself is not...
7.
Onishi H, Uchida N, Itami K, Sato M, Tamura S, Kurosaki A, et al.
Palliat Support Care . 2020 Sep; 18(5):614-616. PMID: 32985409
Objectives: The symptoms of thiamine deficiency vary considerably and asymptomatic cases; i.e., subclinical thiamine deficiency (SCTD), are known to exist. However, there is no information available on the treatment of...
8.
Hasegawa K, Ikeda Y, Kunugi Y, Kurosaki A, Imai Y, Kohyama S, et al.
J Immunother . 2018 Feb; 41(4):201-207. PMID: 29432282
Cancer immunotherapy has now been established as a leading standard therapeutic option in a subset of patients with cancer. In this study, we conducted a phase I dose-escalation trial using...
9.
Sato S, Kato T, Abe K, Hanaoka T, Yano Y, Kurosaki A, et al.
Oncol Lett . 2017 Nov; 14(4):5051. PMID: 29085520
[This corrects the article DOI: 10.3892/ol.2017.6254.].
10.
Sato S, Kato T, Abe K, Hanaoka T, Yano Y, Kurosaki A, et al.
Oncol Lett . 2017 Jul; 14(1):776-786. PMID: 28693233
Krebs von den Lungen-6 (KL-6), a mucinous sialylated sugar chain on human mucin-1 glycoprotein (MUC1), is a diagnostic marker for interstitial lung diseases. Furthermore, elevated serum KL-6 levels have been...